Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fortrea Holdings Inc (FTRE)

Fortrea Holdings Inc (FTRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 979,880
  • Shares Outstanding, K 93,500
  • Annual Sales, $ 2,723 M
  • Annual Income, $ -986,200 K
  • EBIT $ 3 M
  • EBITDA $ 879 M
  • 60-Month Beta 1.80
  • Price/Sales 0.36
  • Price/Cash Flow 1.06
  • Price/Book 1.73

Options Overview Details

View History
  • Implied Volatility 113.56% (-24.92%)
  • Historical Volatility 89.09%
  • IV Percentile 76%
  • IV Rank 37.59%
  • IV High 191.95% on 10/22/25
  • IV Low 66.36% on 03/05/25
  • Expected Move (DTE 16) 1.79 (17.20%)
  • Put/Call Vol Ratio 7.00
  • Today's Volume 8
  • Volume Avg (30-Day) 1,003
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 16,960
  • Open Int (30-Day) 10,878
  • Expected Range 8.60 to 12.17

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.04
  • Number of Estimates 3
  • High Estimate 0.07
  • Low Estimate 0.02
  • Prior Year 0.02
  • Growth Rate Est. (year over year) +100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.05 +14.70%
on 02/26/26
15.98 -35.04%
on 02/05/26
-5.68 (-35.37%)
since 02/04/26
3-Month
9.05 +14.70%
on 02/26/26
18.67 -44.40%
on 01/06/26
-4.12 (-28.41%)
since 12/04/25
52-Week
3.97 +161.46%
on 06/03/25
18.67 -44.40%
on 01/06/26
-0.58 (-5.29%)
since 03/04/25

Most Recent Stories

More News
Q4 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks

Q4 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks

FTRE : 10.38 (-0.95%)
Fortrea (NASDAQ:FTRE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings

Fortrea (NASDAQ:FTRE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings

FTRE : 10.38 (-0.95%)
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance

Revenue and Adjusted EBITDA results delivered in line with stated full-year targets Full‑year cost savings exceeded previously communicated targets Highlights: Revenues of $660.5 million...

FTRE : 10.38 (-0.95%)
Earnings To Watch: Fortrea (FTRE) Reports Q4 Results Tomorrow

Earnings To Watch: Fortrea (FTRE) Reports Q4 Results Tomorrow

FTRE : 10.38 (-0.95%)
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know

iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know

FTRE : 10.38 (-0.95%)
GDRX : 2.18 (+5.31%)
AGL : 0.6985 (+23.11%)
MYGN : 5.28 (-0.19%)
IRTC : 127.95 (+1.67%)
1 Russell 2000 Stock to Target This Week and 2 That Underwhelm

1 Russell 2000 Stock to Target This Week and 2 That Underwhelm

FTRE : 10.38 (-0.95%)
IART : 10.39 (-1.61%)
IONQ : 37.13 (+0.22%)
3 Reasons to Sell FTRE and 1 Stock to Buy Instead

3 Reasons to Sell FTRE and 1 Stock to Buy Instead

FTRE : 10.38 (-0.95%)
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services

DURHAM, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced it has expanded its executive team....

FTRE : 10.38 (-0.95%)
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

DURHAM, N.C., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter...

FTRE : 10.38 (-0.95%)
Fortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE

NEW YORK and NEW ORLEANS , Jan. 20, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti , LLC ("KSF"), announces...

FTRE : 10.38 (-0.95%)

Business Summary

Fortrea Holdings Inc. is a provider of clinical development and patient access solutions to the life sciences industry. It provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea Holdings Inc. is based...

See More

Key Turning Points

3rd Resistance Point 11.33
2nd Resistance Point 11.05
1st Resistance Point 10.71
Last Price 10.38
1st Support Level 10.09
2nd Support Level 9.81
3rd Support Level 9.47

See More

52-Week High 18.67
Fibonacci 61.8% 13.05
Fibonacci 50% 11.32
Last Price 10.38
Fibonacci 38.2% 9.59
52-Week Low 3.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar